Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 467
Immune Disorders Drugs 194
Cardiovascular Drugs 156
Biopharmaceuticals 133
Infectious Diseases Drugs 124
Drug Discovery 107
Central Nervous System Drugs 106
Endocrine and Metabolic Disorders Drugs 103
Clinical Trials 98
Musculoskeletal Disorders Drugs 93
Pharmaceuticals 89
Leukemia Drugs 83
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 65
Dermatological Drugs 58
Diabetes Drugs 54
Skin Cancer Drugs 51
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Respiratory Drugs 39
Immunosuppressive Drugs 37
Gastrointestinal Drugs 33
Infusions and Injectables 32
Drug Delivery 32
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Pharmaceutical Manufacturing 28
Bladder Cancer Drugs 26
Analgesics 26
Drugs by Therapeutic Area 24
Kidney Cancer Drugs 22
Antibiotics 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Prostate Cancer Drugs 17
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Urological Disorders Drugs 16
Schizophrenia Drugs 16
Cancer Vaccines 14
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 5
Pharmacoeconomics 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Vitamins and Dietary Supplements 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,397 Results (Page 81 of 120)
- Relevance
  Sort by

Biologics Market Report 2025

 Report
March 2025
400 Pages
Global

From

€3961EUR$4,490USD£3,479GBP

Chronic Pain Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3961EUR$4,490USD£3,479GBP

Eosinophilic Esophagitis - Market Insight, Epidemiology and Market Forecast - 2034

 Report
October 2024
169 Pages
Global

From

€5610EUR$6,360USD£4,928GBP

€7013EUR$7,950USD£6,161GBP

Anti-Depressant Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
92 Pages
Global

From

€3500EUR$4,251USD£3,182GBP

China Pharmaceutical Contract Manufacturing Services Market, 2020-2030

 Report
March 2020
210 Pages
China

From

€4321EUR$4,899USD£3,796GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Sarcoidosis - Pipeline Insight, 2025

 Clinical Trials
April 2025
75 Pages
Global

From

€1058EUR$1,200USD£930GBP

€1323EUR$1,500USD£1,162GBP

Biologics Market Size, Share & Trends Analysis Report By Source (Microbial, Mammalian), By Product (MABs, Recombinant Proteins, Antisense & RNAi), By Disease Category, By Manufacturing, By Region, And Segment Forecasts, 2023 - 2030

 Report
May 2023
120 Pages
Global

From

€5248EUR$5,950USD£4,611GBP

Sarcoma Drugs Market by Indication, Drugs, Sales Channel, End-User - Global Forecast 2025-2030

 Report
October 2024
184 Pages

From

€3127EUR$3,545USD£2,747GBP

€3475EUR$3,939USD£3,052GBP

T-Cell Lymphoma Market Report: Trends, Forecast and Competitive Analysis to 2030

 Report
November 2023
150 Pages
Global

From

€3396EUR$3,850USD£2,983GBP

€4278EUR$4,850USD£3,758GBP

Cancer Immunotherapy Market by Type (Monoclonal Antibodies, Cancer Vaccines, Check Point Inhibitors & Immunomodulators), Application (Lung, Breast, Colorectal, Melanoma, Prostate, Head & Neck), End User (Hospital and Clinics),Regional Outlook- Global Forecast up to 2030

 Report
January 2024
116 Pages
Global

From

€3969EUR$4,500USD£3,487GBP

Global Markets for Treatments for Syndromes of Progressive Ataxia and Weakness Disorders

 Report
September 2023
180 Pages
Global

From

€4102EUR$4,650USD£3,603GBP

Cancer Immunotherapy Market 2024-2028

 Report
July 2024
180 Pages
Global

From

€2205EUR$2,500USD£1,937GBP

Major Depressive Disorder - Eight-Market Drug Forecast and Market Analysis - Update

 Report
December 2023
117 Pages
Global

From

€13227EUR$14,995USD£11,620GBP

Waldenstrom's Macroglobulinaemia - Pipeline Insight, 2022

 Clinical Trials
November 2022
80 Pages
Global

From

€1411EUR$1,600USD£1,240GBP

€1764EUR$2,000USD£1,550GBP

Targeted Protein Degradation by Proteasomal, Lysosomal & Autophagy Pathways 2022: An Industry Landscape Analysis of Stakeholders, Technologies, Pipeline, Partnering and Financing

 Report
March 2022
553 Pages
Global

From

€2450EUR$2,975USD£2,228GBP

Injectable Drugs Market - Global Forecast 2025-2032

 Report
November 2025
184 Pages
Global

From

€3127EUR$3,545USD£2,747GBP

€3475EUR$3,939USD£3,052GBP

Acute Ischemic Stroke Drugs Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3961EUR$4,490USD£3,479GBP

Proteasome Inhibitors Market 2025-2029

 Report
May 2025
243 Pages
Global

From

€2205EUR$2,500USD£1,937GBP

Gastrointestinal Stromal Tumors Therapeutics Market 2025-2029

 Report
June 2025
214 Pages
Global

From

€2205EUR$2,500USD£1,937GBP

Inotropic Agents Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3961EUR$4,490USD£3,479GBP

2,397 Results (Page 81 of 120)
- 1
- 79
- 80
- 81
- 82
- 83

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.